Drug Name:
TRIAMINIC COLD & ALLERGY OTC
Generic Name and Formulations:
Chlorpheniramine maleate 1mg, phenylephrine HCl 2.5mg; per 5mL; liq; alcohol-free; orange-flavored; contains sodium 3mg/5mL.
Company:
Novartis Consumer Health
Therapeutic Use:
Indications for TRIAMINIC COLD & ALLERGY:
Rhinorrhea, congestion, allergy symptoms.
Children:
<4yrs: do not use. 4–6yrs: individualize. 6–12yrs: 10mL. Repeat every 4 hours as needed; max 6 doses/24 hours.
Contraindications:
Children <4yrs old. During or within 14 days of MAOIs. For use as a sedative hypnotic.
Warnings/Precautions:
Hypertension. Cardiovascular disease. Thyroid disease. Diabetes. Glaucoma. Asthma. Lower respiratory disorders.
Interactions:
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized. Increased CNS effects with other CNS depressants.
Pharmacological Class:
Antihistamine + sympathomimetic.
Adverse Reactions:
Drowsiness, anticholinergic effects, dizziness, nervousness, insomnia, excitability in children.
How Supplied:
Liq—4oz
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine